open access

Vol 84, No 11 (2013)
ARTICLES
Get Citation

Relations between combined oral contraceptive therapy and indices of autonomic balance (baroreflex sensitivity and heart rate variability) in young healthy women

Anna Wilczak, Katarzyna Marciniak, Michał Kłapciński, Agnieszka Rydlewska, Dariusz Danel, Ewa A. Jankowska
DOI: 10.17772/gp/1660
·
Ginekol Pol 2013;84(11).

open access

Vol 84, No 11 (2013)
ARTICLES

Abstract

Introduction: There are structural and functional links between autonomic nervous and endocrine systems. Derivatives of estrogens and gestagens applied in combined oral contraceptives (COC) reduce the production of endogenous sex steroids, but their effect on autonomic nervous system remains unknown. Aim: To compare indices of heart rate variability (HRV) and baroreflex sensitivity (BRS) among young healthy women taking vs. non-taking COC. Material and methods: We performed a cross-sectional study in a group of 53 healthy women (age: 23±3 years, BMI: 22.3±2.8 kg/m2) taking COC for ≥ 3 months (COC-group) and in a group of 113 healthy women (age: 24±4 years, BMI: 22.0±3.1 kg/m2) not taking COC for ≥3 months (n-COC-group). All examined women were between the 4th and the 8th day of menstrual (or pill-driven) cycle lasting from 21 to 35 days. Indices of autonomic balance was assessed based on the time- and frequency- domains of heart rate variability (HRV, very low (VLF), low (LF), high (HF) frequencies and total HRV spectrum). BRS was evaluated using the sequence (BRS-Seq) and the controlled breathing (BRS-CtBr) methods. Results: There were no differences in: age, weight, height, measures of adiposity and fat distribution, the menstrual (or pill-driven) cycle day on the day of examination, heart rate and HRV parameters between the two studied groups (all p>0.1). BRS-CtBr was higher among n-COC-group as compared to COC-group (20.00±6.28 vs. 18.07±6.57 ms/mmHg, p<0.05). There was a trend towards higher BRS-Seq in the n-COC-group as compared to the COCgroup (19.47±7.85 vs. 16.95±5.76 ms/mmHg, p=0.12). In the n-COC-group, BRS-CtBr and RMSSD were inversely related to age (r=-0.23, r=-0.19, p<0.05). In the COC-group, SDNN was inversely related to waist circumference and WHR (respectively r=-0.34 and r=-0.35, both p<0.05). Conclusions: COC impair the reflex regulation of cardiovascular system based on baroreflex, which may indicate unfavorable influence of COC use on women`health. The exact mechanism of BRS impairment caused by COC remains unknown, also in the context of the different composition of various COC. Thus, it needs to be studied further.

Abstract

Introduction: There are structural and functional links between autonomic nervous and endocrine systems. Derivatives of estrogens and gestagens applied in combined oral contraceptives (COC) reduce the production of endogenous sex steroids, but their effect on autonomic nervous system remains unknown. Aim: To compare indices of heart rate variability (HRV) and baroreflex sensitivity (BRS) among young healthy women taking vs. non-taking COC. Material and methods: We performed a cross-sectional study in a group of 53 healthy women (age: 23±3 years, BMI: 22.3±2.8 kg/m2) taking COC for ≥ 3 months (COC-group) and in a group of 113 healthy women (age: 24±4 years, BMI: 22.0±3.1 kg/m2) not taking COC for ≥3 months (n-COC-group). All examined women were between the 4th and the 8th day of menstrual (or pill-driven) cycle lasting from 21 to 35 days. Indices of autonomic balance was assessed based on the time- and frequency- domains of heart rate variability (HRV, very low (VLF), low (LF), high (HF) frequencies and total HRV spectrum). BRS was evaluated using the sequence (BRS-Seq) and the controlled breathing (BRS-CtBr) methods. Results: There were no differences in: age, weight, height, measures of adiposity and fat distribution, the menstrual (or pill-driven) cycle day on the day of examination, heart rate and HRV parameters between the two studied groups (all p>0.1). BRS-CtBr was higher among n-COC-group as compared to COC-group (20.00±6.28 vs. 18.07±6.57 ms/mmHg, p<0.05). There was a trend towards higher BRS-Seq in the n-COC-group as compared to the COCgroup (19.47±7.85 vs. 16.95±5.76 ms/mmHg, p=0.12). In the n-COC-group, BRS-CtBr and RMSSD were inversely related to age (r=-0.23, r=-0.19, p<0.05). In the COC-group, SDNN was inversely related to waist circumference and WHR (respectively r=-0.34 and r=-0.35, both p<0.05). Conclusions: COC impair the reflex regulation of cardiovascular system based on baroreflex, which may indicate unfavorable influence of COC use on women`health. The exact mechanism of BRS impairment caused by COC remains unknown, also in the context of the different composition of various COC. Thus, it needs to be studied further.
Get Citation

Keywords

Combined oral contraceptives, autonomic nervous system, cardiovascular reflex regulation, baroreflex sensivity, heart rate variability

About this article
Title

Relations between combined oral contraceptive therapy and indices of autonomic balance (baroreflex sensitivity and heart rate variability) in young healthy women

Journal

Ginekologia Polska

Issue

Vol 84, No 11 (2013)

Page views

1037

Article views/downloads

911

DOI

10.17772/gp/1660

Bibliographic record

Ginekol Pol 2013;84(11).

Keywords

Combined oral contraceptives
autonomic nervous system
cardiovascular reflex regulation
baroreflex sensivity
heart rate variability

Authors

Anna Wilczak
Katarzyna Marciniak
Michał Kłapciński
Agnieszka Rydlewska
Dariusz Danel
Ewa A. Jankowska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl